Naloxone and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naloxone (naloxone hydrochloride) and Thalidomide (thalidomide). Common drug interactions include atrial fibrillation among females and acute generalised exanthematous pustulosis among males.

The phase IV clinical study analyzes what interactions people have when they take Naloxone and Thalidomide. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Naloxone?

Naloxone has active ingredients of naloxone hydrochloride. eHealthMe is studying from 6,425 Naloxone users. Check the latest studies of Naloxone.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

33 people who take Naloxone and Thalidomide together, and have interactions are studied.

Naloxone and Thalidomide drug interactions.

What are the common drug interactions of Naloxone and Thalidomide, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Fall
  3. Unresponsive to stimuli
  4. Abdominal discomfort
  5. Abdominal mass (localized enlargement or swelling in the human abdomen)
  6. Abscess soft tissue (soft tissue abscesses)
  7. Acquired oesophageal web (structural abnormalities in the oesophagus)
  8. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  9. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  10. Anaemia (lack of blood)

male:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Cyst (a closed sac)
  7. Cytomegalovirus infection
  8. Decreased interest
  9. Dehydration (dryness resulting from the removal of water)
  10. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)

What are the common drug interactions of Naloxone and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Ewing's sarcoma (malignant small, round, blue cell tumour)

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Blood magnesium decreased
  6. Blood sodium decreased
  7. Bone disorder
  8. Bone marrow disorder
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)

50-59:

n/a

60+:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Haemoglobin decreased
  4. Haematocrit decreased
  5. Oropharyngeal pain
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  8. Pustular psoriasis (raised bumps on the skin that are filled with pus)
  9. White blood cell count decreased
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 10 people, 30.30%
  2. Stress And Anxiety: 2 people, 6.06%
  3. Pain: 2 people, 6.06%
  4. Constipation: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Naloxone and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naloxone and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naloxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naloxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride and thalidomide (the active ingredients of Naloxone and Thalidomide, respectively), and Naloxone and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: